cl 184005 has been researched along with Staphylococcal Infections in 2 studies
*Staphylococcal Infections: Infections with bacteria of the genus STAPHYLOCOCCUS. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Connolly, RJ; Dinarello, CA; Dirkes, K; Gelfand, JA; Harris, BH; Schwaitzberg, SD | 1 |
| DeJoy, SQ; Jeyaseelan, R; Kerwar, SS; Oronsky, AL; Pickett, WC; Torley, LW; Wick, MM; Wissner, A | 1 |
2 other study(ies) available for cl 184005 and Staphylococcal Infections
| Article | Year |
|---|---|
Platelet activating factor-antagonist improves survival in experimental staphylococcal septicemia.
Topics: Animals; Hemodynamics; Leukocyte Count; Organophosphorus Compounds; Platelet Activating Factor; Platelet Count; Rabbits; Sepsis; Staphylococcal Infections; Staphylococcus epidermidis; Thiazoles | 1994 |
Effect of CL 184,005, a platelet-activating factor antagonist in a murine model of Staphylococcus aureus-induced gram-positive sepsis.
Topics: Animals; Blood Pressure; Disease Models, Animal; Dose-Response Relationship, Drug; Enterotoxins; Interleukin-6; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Organophosphorus Compounds; Platelet Activating Factor; Staphylococcal Infections; Thiazoles; Time Factors; Tumor Necrosis Factor-alpha | 1994 |